
Aptevo Therapeutics Inc (APVO) Dividend History
Aptevo Therapeutics Inc. is a biotechnology company focused on developing innovative immuno-oncology and hematology therapies. The company specializes in leveraging its proprietary ADAPTIR® bispecific antibody platform to create treatments aimed at improving outcomes for patients with cancer and blood disorders. Founded with a focus on immunotherapy, Aptevo integrates advanced scientific research with clinical development to address unmet medical needs.
Dividend History
Aptevo Therapeutics Inc currently does not pay dividends
Company News
-
Zacks Investment Research
-
Zacks Investment Research
-
Zacks Investment Research